Lucian Iancovici
Director, TPG Life Science Innovations at TPG Global
San Diego, California
Overview
Work Experience
Partner and Managing Director, TPG Life Science Innovations
2018 - Current
Senior Advisor at TPG Growth
2018 - 2018
TPG is a private investment firm that manages capital across a series of funds.
Raised $535,598,425.00 from Macquarie Group, Ares Management, Nomura Holdings, Pierfront Capital, Kohlberg Kravis Roberts, Partners Group and Barings.
Partner
2017
FS Investors is a private investment entity with a long term, captive pool of capital.
General Partner
2015 - 2017
dRx Capital AG is a joint venture investment company launched by Novartis and Qualcomm with a capital commitment up to $100M. We strive to catalyze the success of digital medicine products, services and business models by investing in early-stage companies and leveraging our extensive networks in Pharma, Mobile/IT, and investment community
Head of Qualcomm Life Fund
2012 - 2017
Lucian is responsible for the $100M Qualcomm Life Fund (QLF) at Qualcomm Ventures, which focuses on investing in digital healthcare companies. Since Lucian joined Qualcomm Ventures in 2012, he has helped establish QLF as one of the most widely recognized and respected funds in the space, cited as among the most active today by numerous sources including CB Insights, Rock Health, and Startup Health.
Qualcomm Ventures is a global investor that assists entrepreneurs in creating revolutionary businesses.
Associate
2011 - 2012
McKinsey Growth Tech serves leading growth stage tech players, venture capital, and growth private equity
Housestaff Physician - Internal Medicine
2008 - 2011
Columbia University Irving Medical Center is a clinical and educational enterprise that offers medical, dental, and nursing services.